Peter Staley, et al., v. Gilead Sciences, Inc., et al. — Case Page

On October 25, 2019, Juelsgaard Clinic students Mondee Lu and Annie Wanless submitted an amicus curiae brief on behalf of eight HIV research, policy, and advocacy organizations: Treatment Action Group (TAG), AIDS Action Baltimore (AAB), The Foundation for AIDS Research (“amfAR”), AVAC: Global Advocacy for HIV Prevention, Health GAP (Global Access Project), Housing Works, The SERO Project, and the U.S. PLHIV Caucus in this antitrust case in the Northern District of California. The brief urged the court to deny Gilead’s and the other defendants’ motions to dismiss the plaintiffs’ Complaint against them for anticompetitive actions that kept generic HIV drugs out of the market, kept prices artificially high, and harmed Americans who need HIV drugs for treatment and prevention.

JIPIC Amicus Filings:

Federal Trade Commission Amicus Filings

Plaintiffs’ Opposition to Motions to Dismiss

Defendants’ Motions to Dismiss the Complaint:

Gilead Agreements with Other defendants (redacted versions as filed on the court docket by Gilead)

Corrected Consolidated Class Action Complaint (filed Aug. 22, 2019)

Juelsgaard Clinic homepage

Amicus brief FAQs